Immunosuppressive medication

Immunosuppressive medication

Drugs given to a transplant recipient to prevent his or her immune system from attacking the transplanted organ.
References in periodicals archive ?
In a new report, researchers reviewed the medical record of 7 children (aged 7-16 years) with Crohn's disease who had followed the Specific Carbohydrate Diet and had not received immunosuppressive medication.
Cyclosporine is a common immunosuppressive medication, for which serum concentrations are often tracked in patients with transplants.
To determine the risk of shingles in a population taking immunosuppressive medication, Dr.
They survived for more than four weeks in the rat heart without being rejected by the recipient's immune system, even without immunosuppressive medication.
Even if the transplant is successful, you have to take immunosuppressive medication for the rest of your life.
Prednisone, a steroid, is an immunosuppressive medication that is often used to treat MS attacks.
These cells may contribute to establish immunotolerance of liver transplant and to reduce toxicity of immunosuppressive medication.
are free-living amebae that cause granulomatous amebic encephalitis (GAE), most often in immunocompromised hosts, including HIV/AIDS and organ transplant patients and those receiving immunosuppressive medication (1).
The diagnosis of autoimmune sensorineural hearing loss (AISNHL) is ascertained by the history, clinical findings, response to immunosuppressive medication, and an immunologic evaluation of the patient's serum.
Until recently, the primary treatment option for sympathetic ophthalmia was non-surgical and involved high doses of oral steroids followed by oral immunosuppressive medication to preserve vision in a patient's remaining eye," said Vinit Mahajan, M.
Tacrolimus is a leading immunosuppressive medication to prevent rejection after organ transplantation.
In the laboratory study, the hAMCs: transformed into heart muscle cells, with 33% beating spontaneously; improved function of rat hearts 35% to 39% when injected two weeks after a heart attack, while untreated hearts continued to decline in function; decreased the scarred area of damaged rat hearts 18% to 18% when injected after a heart attack; and survived for more than four weeks in the rat heart without being rejected by the recipient's immune system, even without immunosuppressive medication.